Stockscreener 앱 받기
7.78
5.71%
0.42
시장 영업 전:
7.52
-0.26
-3.34%
전일 마감가:
$7.36
열려 있는:
$7.45
하루 거래량:
58,158
Relative Volume:
0.37
시가총액:
$86.41M
수익:
$2.09M
순이익/손실:
$-5.28M
주가수익비율:
-11.61
EPS:
-0.67
순현금흐름:
$-3.64M
1주 성능:
-1.27%
1개월 성능:
+53.45%
6개월 성능:
+36.97%
1년 성능:
+178.85%
1일 변동 폭
$7.432
$8.17
1주일 범위
$7.10
$8.54
52주 변동 폭
$2.22
$11.78
Nutriband Inc Stock (NTRB) Company Profile
명칭
Nutriband Inc
전화
407 377-6695
주소
121 S. ORANGE AVE., ORLANDO
NTRB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
7.78 | 86.41M | 2.09M | -5.28M | -3.64M | -0.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
482.28 | 124.20B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
697.05 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
651.30 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.00 | 34.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.14 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-22 | 개시 | Noble Capital Markets | Outperform |
Nutriband Inc 주식(NTRB)의 최신 뉴스
Nutriband Inc. (NASDAQ:NTRB) Short Interest Down 24.4% in January - MarketBeat
Why Nutriband Inc (NTRB) Is Skyrocketing So Far In 2025 - Yahoo Finance
(NTRB) Proactive Strategies - Stock Traders Daily
NutriBand Shareholders Approve Key Proposals at Annual Meeting - MSN
NutriBand Shareholders Approve Key Proposals at Annual Meeting By Investing.com - Investing.com UK
Nutriband (NASDAQ:NTRBW) Stock Price Down 10.7% – Time to Sell? - Defense World
Noble Financial Predicts Nutriband FY2025 Earnings - Defense World
Nutriband Stock Soars to 52-Week High of $9.6 Amidst Strong Growth - MSN
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica - ACCESS Newswire
Analysts Set Expectations for Nutriband FY2025 Earnings - MarketBeat
Nutriband Stock Soars to 52-Week High of $9.6 Amidst Strong Growth By Investing.com - Investing.com South Africa
Noble Financial Begins Coverage on Nutriband (NASDAQ:NTRB) - MarketBeat
Noble Capital sets Nutriband stock Outperform with $13 target - MSN
Noble Capital sets Nutriband stock Outperform with $13 target By Investing.com - Investing.com Australia
Noble Capital Markets Initiates Coverage of Nutriband (NTRB) with Outperform Recommendation - MSN
Most Shareholders Will Probably Find That The Compensation For Nutriband Inc.'s (NASDAQ:NTRB) CEO Is Reasonable - Simply Wall St
Geode Capital Management LLC Has $351,000 Position in Nutriband Inc. (NASDAQ:NTRB) - Defense World
Shareholders in Nutriband (NASDAQ:NTRB) are in the red if they invested five years ago - Yahoo Finance
Investors ignore increasing losses at Nutriband (NASDAQ:NTRB) as stock jumps 19% this past week - Simply Wall St
Nutriband Inc. Extends Chinese Patent to Macao for AVERSA™ Abuse Deterrent Transdermal Technology - Defense World
Nutriband Issues Letter to Shareholders - GlobeNewswire
Nutriband Expands AVERSA™ Patent to Macao - TipRanks
Nutriband extends Chinese patent to Macao for AVERSA technology - Yahoo Finance
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology - GlobeNewswire
Nutriband (NASDAQ:NTRB) Trading 1.5% Higher – Time to Buy? - Defense World
Nutriband Reports Record Q3 Revenue, Up 51% YOY; Advances AVERSA Fentanyl Development | NTRBW Stock News - StockTitan
Nutriband Reports Record Q3 Revenue, Up 51% YOY; Advances AVERSA Fentanyl Development | NTRB Stock News - StockTitan
Nutriband Inc. Quarterly Report Highlights Record Revenue - GlobeNewswire
Nutriband Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2024 - Marketscreener.com
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th - The Manila Times
Nutriband to Showcase Revolutionary Abuse-Deterrent Technology at Noble Conference - StockTitan
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - Yahoo Finance
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology - The Manila Times
Nutriband Secures Hong Kong Patent for Abuse-Deterrent Patch Technology, Eyes $200M Market | NTRB Stock News - StockTitan
(NTRB) Technical Pivots with Risk Controls - Stock Traders Daily
Nutriband (NASDAQ:NTRB) Receives Full Patent Approval for AVERSA™ Abuse and Misuse Deterrent Transdermal SystemORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB) has recently disclosed that the Chinese National Intel - Defense World
Nutriband Secures Chinese Patent for AVERSA™ Technology - TipRanks
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application - AccessWire
(NTRB) Technical Data - Stock Traders Daily
Nutriband (NASDAQ:NTRB) Stock Price Down 8.1%Time to Sell? - MarketBeat
Nutriband (NASDAQ:NTRB) Stock Price Down 8.1% – Here’s What Happened - Defense World
(NTRB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Nutriband Inc (NTRB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.02%
0.32%
자본화:
|
볼륨(24시간):